Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Emerging hepatitis B virus infection in vaccinated populations: a rising concern?

Su TH, Chen PJ.

Emerg Microbes Infect. 2012 Sep;1(9):e27. doi: 10.1038/emi.2012.28. Epub 2012 Sep 19. Review.

2.

Occult hepatitis B virus infection.

Kwak MS, Kim YJ.

World J Hepatol. 2014 Dec 27;6(12):860-9. doi: 10.4254/wjh.v6.i12.860. Review.

3.
4.

Risk factors for de novo hepatitis B infection in pediatric living donor liver transplantation.

Rao W, Xie M, Yang T, Zhang JJ, Gao W, Deng YL, Zheng H, Pan C, Liu YH, Shen ZY.

World J Gastroenterol. 2014 Sep 28;20(36):13159-66. doi: 10.3748/wjg.v20.i36.13159.

5.

High prevalence of occult hepatitis B virus genotype H infection among children with clinical hepatitis in west Mexico.

Escobedo-Melendez G, Panduro A, Fierro NA, Roman S.

Mem Inst Oswaldo Cruz. 2014 Sep;109(6):728-37. Epub 2014 Aug 5.

6.

Prevalence of occult hepatitis B virus infection in kidney transplant recipients.

Franz C, Perez Rde M, Zalis MG, Zalona AC, Rocha PT, Gonçalves RT, Nabuco LC, Villela-Nogueira CA.

Mem Inst Oswaldo Cruz. 2013 Aug;108(5):657-60.

7.

Hepatitis B viral DNA among HBs antigen negative healthy blood donors.

Vaezjalali M, Rashidpour S, Rezaee H, Hajibeigi B, Zeidi M, Gachkar L, Aghamohamad S, Najafi R, Goudarzi H.

Hepat Mon. 2013 Mar 17;13(3):e6590. doi: 10.5812/hepatmon.6590. Print 2013 Mar.

8.

Occult hepatitis B: clinical viewpoint and management.

Zobeiri M.

Hepat Res Treat. 2013;2013:259148. doi: 10.1155/2013/259148. Epub 2013 Mar 4.

9.

Limited infection with occult hepatitis B virus in drug users in the USA.

Blackard JT, Martin CM, Sengupta S, Forrester J.

Hepatol Res. 2013 Apr;43(4):413-7. doi: 10.1111/j.1872-034X.2012.01072.x. Epub 2012 Aug 22.

10.

Prevalence of hepatitis B & hepatitis C virus infections in potential blood donors in rural Vietnam.

Viet L, Lan NT, Ty PX, Björkvoll B, Hoel H, Gutteberg T, Husebekk A, Larsen S, Skjerve E, Husum H.

Indian J Med Res. 2012 Jul;136(1):74-81.

11.

Pre- and post-transfusion testing for hepatitis B virus surface antigen and antibody in blood recipients: a single-institution experience in an area of high endemicity.

Kim H, Hur M, Moon HW, Park CM, Cho JH, Park KS, Lee K, Chang S.

Ann Lab Med. 2012 Jan;32(1):73-8. doi: 10.3343/alm.2012.32.1.73. Epub 2011 Dec 20.

12.

Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authorities.

Arababadi MK, Hassanshahi G, Pourfathollah AA, Zarandi ER, Kennedy D.

Hepat Mon. 2011 Sep;11(9):714-8. doi: 10.5812/kowsar.1735143X.694.

13.

An overview of occult hepatitis B virus infection.

Said ZN.

World J Gastroenterol. 2011 Apr 21;17(15):1927-38. doi: 10.3748/wjg.v17.i15.1927. Review.

14.

Management of occult hepatitis B virus infection: an update for the clinician.

Lledó JL, Fernández C, Gutiérrez ML, Ocaña S.

World J Gastroenterol. 2011 Mar 28;17(12):1563-8. doi: 10.3748/wjg.v17.i12. 1563. Review.

15.

Pathogenesis of occult chronic hepatitis B virus infection.

de la Fuente RA, Gutiérrez ML, Garcia-Samaniego J, Fernández-Rodriguez C, Lledó JL, Castellano G.

World J Gastroenterol. 2011 Mar 28;17(12):1543-8. doi: 10.3748/wjg.v17.i12. 1543. Review.

16.

Repeated passage of wild-type woodchuck hepatitis virus in lymphoid cells does not generate cell type-specific variants or alter virus infectivity.

Mulrooney-Cousins PM, Michalak TI.

J Virol. 2008 Aug;82(15):7540-50. doi: 10.1128/JVI.00405-08. Epub 2008 May 21.

17.

Persistent occult hepatitis B virus infection: experimental findings and clinical implications.

Mulrooney-Cousins PM, Michalak TI.

World J Gastroenterol. 2007 Nov 21;13(43):5682-6. Review.

18.

Molecular testing in the diagnosis and management of chronic hepatitis B.

Valsamakis A.

Clin Microbiol Rev. 2007 Jul;20(3):426-39, table of contents. Review.

19.

Transfusion-transmitted infections.

Bihl F, Castelli D, Marincola F, Dodd RY, Brander C.

J Transl Med. 2007 Jun 6;5:25. Review.

20.

Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study.

Laperche S, Thibault V, Bouchardeau F, Alain S, Castelain S, Gassin M, Gueudin M, Halfon P, Larrat S, Lunel F, Martinot-Peignoux M, Mercier B, Pawlotsky JM, Pozzetto B, Roque-Afonso AM, Roudot-Thoraval F, Sauné K, Lefrère JJ.

J Clin Microbiol. 2006 Oct;44(10):3600-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk